Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.

Investlytic score: 2/5 criteria met. Data as of 03/10/2026.
- ❌ Price trend failed
- ✅ Growth passed
- ❌ Debt failed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: 17.19%
Price change 2019 → 2020: -1.96%
Price change 2020 → 2021: 56.79%
Price change 2021 → 2022: -29.00%
Price change 2022 → 2023: 12.56%
Price change 2023 → 2024: -2.66%
Price change 2024 → 2025: -12.27%
Price change 2025 → 2026: -16.27%
Price change 2026 (year to date): -15.63%
Financial growth
Revenue CAGR (8 years): 8.24%
Earnings CAGR (8 years): 7.83%
Growth status: positive trend (>1%/yr) in revenue and earnings.
Debt
Debt-to-equity ratio: 0.83
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 15.86
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 6.88% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Siemens Healthineers AG | 18.7 | 0.83 | +5.6 % | 🔒 |
| Lonza Group AG | 41.8 | 0.50 | +6.1 % | – |
| Becton, Dickinson and Company | 16.8 | 0.76 | +6.5 % | – |
| Bayer AG | 11.7 | 1.44 | +1.8 % | – |
| Boston Scientific Corporation | 14.3 | 0.51 | +6.5 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by Siemens Healthineers AG over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2021 | 19.8 bn | 1.9 bn | 9.6 % | n/a |
| 2022 | 23.9 bn | 2.2 bn | 9.4 % | +20.7 % |
| 2023 | 23.9 bn | 1.7 bn | 7.0 % | -0.2 % |
| 2024 | 24.7 bn | 2.1 bn | 8.7 % | +3.2 % |
| 2025 | 25.8 bn | 2.4 bn | 9.2 % | +4.5 % |
| 2026 | 26.0 bn | 2.4 bn | 9.4 % | +1.1 % |
Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.
Accounts and financial health
Balance sheet and cash flow published by Siemens Healthineers AG over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash and investments | 1.4 bn | 1.6 bn | 2.7 bn | 2.2 bn | 3.0 bn |
| Total Debt | 16.7 bn | 16.7 bn | 16.2 bn | 15.1 bn | 14.7 bn |
| Net Debt | 15.2 bn | 15.0 bn | 13.5 bn | 12.9 bn | 12.2 bn |
| Equity | 19.8 bn | 18.1 bn | 18.2 bn | 18.0 bn | 19.8 bn |
| Total assets | 49.1 bn | 46.7 bn | 46.1 bn | 44.4 bn | 46.7 bn |
| Operating cash flow | 2.3 bn | 1.8 bn | 2.5 bn | 3.1 bn | 3.3 bn |
| Investments (capex) | 852 m | 838 m | 696 m | 818 m | 842 m |
| Free cash-flow | 1.4 bn | 971 m | 1.8 bn | 2.3 bn | 2.4 bn |
| Share buybacks | 309 m | 421 m | 10.0 m | 301 m | 161 m |
| Dividends paid | 955 m | 1.1 bn | 1.1 bn | 1.1 bn | 1.1 bn |
Amounts in EUR, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.
Valuation and competitors
Siemens Healthineers AG compared with its sector on the same exchange and with its main competitors.
Direct competitors
| Company | Market cap (USD) | P/E | Net margin |
|---|---|---|---|
| Siemens Healthineers AG | 55.7 bn | 19.0 | 9.2 % |
| GE HealthCare Technologies Inc. GEHC | 37.2 bn | 16.8 | 10.1 % |
| Drägerwerk AG & Co. KGaA DRW3.DE | 1.9 bn | 11.3 | 4.0 % |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 300760.SZ | 33.5 bn | 28.6 | 24.4 % |
| Sector median (Xetra) | 32.5 |
Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 16/11/2026. Competitors: comparable companies named by the data provider.
Analyst consensus and forecasts
What the financial analysts covering Siemens Healthineers AG publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Price targets: published for companies listed in the United States only.
Analyst forecasts
| Fiscal year | Revenue | Net income | Expected EPS (range) | P/E on this EPS | Analysts |
|---|---|---|---|---|---|
| 2026 | 23.6 bn | 2.6 bn | 2.35 (2.22 / 2.41) | 19.0 | 16 |
| 2027 | 25.1 bn | 2.7 bn | 2.36 (2.30 / 2.50) | 18.9 | 17 |
| 2028 | 26.6 bn | 3.1 bn | 2.69 (2.39 / 3.25) | 16.6 | 15 |
Amounts in EUR, the reporting currency.
Track record against expectations: reported EPS above consensus 9 times over the last 12 releases.
Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee.
Dividends and earnings
Siemens Healthineers AG: dividend history, last distributions, stock splits and earnings releases.
Annual dividend per share (EUR), adjusted for splits. Light bar: current year, incomplete. Red bar: lower than the previous year.
Latest ex-dividend dates
| Ex-dividend | Amount | Payment |
|---|---|---|
| 06/02/2026 | 1.00 EUR | 10/02/2026 |
| 19/02/2025 | 0.950 EUR | 21/02/2025 |
| 19/04/2024 | 0.950 EUR | 23/04/2024 |
| 16/02/2023 | 0.950 EUR | 20/02/2023 |
| 16/02/2022 | 0.850 EUR | 18/02/2022 |
| 15/02/2021 | 0.800 EUR | 17/02/2021 |
| 13/02/2020 | 0.800 EUR | 17/02/2020 |
| 06/02/2019 | 0.700 EUR | 08/02/2019 |
Earnings releases
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 05/11/2026 | 0.70 | 0.68 | +2.9 % |
| 31/07/2026 | 0.69 | 0.52 | +32.5 % |
| 07/05/2026 | 0.52 | 0.50 | +5.0 % |
| 05/02/2026 | 0.49 | 0.44 | +9.9 % |
| 05/11/2025 | 0.69 | 0.70 | -1.1 % |
| 30/07/2025 | 0.65 | 0.54 | +20.8 % |
Factual data: ex-dividend history and earnings calendar, as of 15/11/2026. A past dividend does not guarantee the next one.
Who owns the stock
Free float, institutional investors, large funds, executives and elected officials: declared positions in Siemens Healthineers AG.
Sources: 13F filings (quarter shown), executives' Form 4 filings and US Congress members' disclosures, collected on 07/11/2026. Detailed disclosure obligations mainly apply to companies listed in the United States.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about Siemens Healthineers AG
What is the Siemens Healthineers AG share price?
Latest recorded price: 43.95 EUR on 13/11/2026, for a market cap of 54.2 bn USD.
What is the revenue of Siemens Healthineers AG?
26.0 bn USD for fiscal year 2026, with net income of 2.4 bn USD (net margin 9.4 %).
Does Siemens Healthineers AG pay a dividend?
Yes. Latest dividend: 1.00 EUR per share, ex-dividend on 06/02/2026. Over 12 months: 1.00 EUR. Yield on the latest known price: 2.1 %.
When does Siemens Healthineers AG report its next earnings?
The next release is expected on 04/02/2027. EPS expected by analysts: 0.50.
What do analysts say about Siemens Healthineers AG?
Out of 2 analysts: 1 buy or strong buy, 1 hold, 0 sell or strong sell.
What is the P/E ratio of Siemens Healthineers AG?
Trailing 12-month P/E of 18.7, against 32.5 for the sector median on the same exchange (10-year median: 26.9).
Is Siemens Healthineers AG stock eligible for the French PEA?
Likely: the company is headquartered in the European Union or the European Economic Area (ISIN DE000SHL1006) and the stock is listed on a European exchange. The institution holding the PEA confirms eligibility.
How many employees does Siemens Healthineers AG have?
72,000 full-time employees according to the latest published profile.
Who runs Siemens Healthineers AG?
Bernhard Montag is the company's chief executive.